JESSE J GEIGER, the President of $MEDP, sold 41,801 shares of the company on 07-24-2025 for an estimated $18,940,451. We received data on the trade from a recent SEC filing. This was a sale of approximately 53.4% of their shares of this class of stock. Following this trade, they now own 36,503 shares of this class of $MEDP stock.
$MEDP Insider Trading Activity
$MEDP insiders have traded $MEDP stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- JESSE J GEIGER (President) sold 41,801 shares for an estimated $18,940,451
- KEVIN M. BRADY (CFO & Treasurer) sold 12,000 shares for an estimated $5,450,760
- BRIAN T CARLEY sold 4,003 shares for an estimated $1,383,396
- FRED B JR DAVENPORT sold 1,712 shares for an estimated $516,715
- STEPHEN P EWALD (General Counsel & Corp. Secy.) purchased 2 shares for an estimated $652
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MEDP Hedge Fund Activity
We have seen 277 institutional investors add shares of $MEDP stock to their portfolio, and 283 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAWER INVESTMENT MANAGEMENT LTD. added 696,219 shares (+inf%) to their portfolio in Q1 2025, for an estimated $212,130,967
- CAPITAL WORLD INVESTORS removed 434,736 shares (-99.2%) from their portfolio in Q1 2025, for an estimated $132,459,711
- PROFICIO CAPITAL PARTNERS LLC removed 241,751 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $73,659,112
- VULCAN VALUE PARTNERS, LLC added 224,578 shares (+221.6%) to their portfolio in Q1 2025, for an estimated $68,426,670
- GOLDMAN SACHS GROUP INC removed 159,008 shares (-36.0%) from their portfolio in Q1 2025, for an estimated $48,448,147
- CAMBER CAPITAL MANAGEMENT LP removed 125,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $38,086,250
- KENSICO CAPITAL MANAGEMENT CORP removed 121,100 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $36,897,959
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MEDP Analyst Ratings
Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 07/25/2025
- TD Cowen issued a "Sell" rating on 07/23/2025
To track analyst ratings and price targets for $MEDP, check out Quiver Quantitative's $MEDP forecast page.
$MEDP Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 7 analysts offer price targets for $MEDP in the last 6 months, with a median target of $436.0.
Here are some recent targets:
- Ann Hynes from Mizuho set a target price of $510.0 on 07/25/2025
- Luke Sergott from Barclays set a target price of $450.0 on 07/23/2025
- Charles Rhyee from TD Cowen set a target price of $366.0 on 07/23/2025
- Eric Coldwell from Baird set a target price of $490.0 on 07/23/2025
- Jailendra Singh from Truist Securities set a target price of $436.0 on 07/23/2025
- Justin Bowers from Deutsche Bank set a target price of $430.0 on 07/23/2025
- Michael Cherny from Leerink Partners set a target price of $330.0 on 03/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
